Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL86001 | 0.84 | ATM (0.41) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL8144898 | 0.82 | ATM (0.43) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL8675243 | 0.81 | ATM (0.39) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL28708577 | 0.79 | ATM (0.38) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL85767 | 0.79 | ATM (0.44) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL22930710 | 0.77 | ATM (0.44) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL4455196 | 0.77 | ATM (0.36) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL15235937 | 0.76 | ATM (0.46) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL15827671 | 0.76 | ATM (0.41) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL4468463 | 0.76 | ATM (0.41) | ATMNPC1KMT2AGPR35ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7473795-B2 | Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2009-01-06 | — | — | US | claimed |
| US-20060155140-A1 | Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors | UNIROYAL CHEMICAL COMPANY, INC A CORPORATION OF THE STATE OF DELAWARE | 2006-07-13 | — | — | US | claimed |
| US-7045647-B2 | Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2006-05-16 | — | — | US | claimed |
| EP-1379584-B1 | FLAME RETARDANT COMPOSITIONS | CIBA SC HOLDING AG (CH) | 2005-08-24 | — | — | EP | claimed |
| US-20040097619-A1 | Flame retardant compositions | CIBA SPECIALTY CHEMICALS CORP. | 2004-05-20 | — | — | US | claimed |
| US-20040010159-A1 | Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors | ADDIVANT USA, LLC | 2004-01-15 | — | — | US | claimed |
| EP-1379584-A1 | FLAME RETARDANT COMPOSITIONS | Ciba Specialty Chemicals Holding Inc. (CH) | 2004-01-14 | — | — | EP | claimed |
| EP-1332196-A1 | BLENDS OF QUINONE ALKIDE AND NITROXYL COMPOUNDS AS POLYMERIZATION INHIBITORS | Uniroyal Chemical Company, Inc. (US) | 2003-08-06 | — | — | EP | claimed |
| WO-2002074847-A1 | FLAME RETARDANT COMPOSITIONS | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 2002-09-26 | — | — | WO | claimed |
| WO-2002033026-A1 | BLENDS OF QUINONE ALKIDE AND NITROXYL COMPOUNDS AS POLYMERIZATION INHIBITORS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2002-04-25 | — | — | WO | claimed |
| US-5670692-A | 7-substituted quinone methides as inhibitors for unsaturated monomers | CIBA-GEIGY CORPORATION (US) | 1997-09-23 | — | — | US | claimed |
| US-5583247-A | PREMATURE POLYMERIZATION STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1996-12-10 | — | — | US | claimed |
| WO-2021032518-A1 | A PROCESS FOR THE PRODUCTION OF FINGERPRINT TEXTURE FREE LIQUID CRYSTAL FILMS | BASF SE (DE) | 2021-02-25 | — | — | WO | disclosed |
| US-7473795-B2 | Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2009-01-06 | — | — | US | disclosed |
| US-7470734-B2 | Flame retardant compositions | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-12-30 | — | — | US | disclosed |
| US-7084196-B2 | Flame retardant compositions | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-08-01 | — | — | US | disclosed |
| US-5750765-A | 7-substituted quinone methides as inhibitors for unsaturated monomers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-05-12 | — | — | US | disclosed |
| US-5670692-A | 7-substituted quinone methides as inhibitors for unsaturated monomers | CIBA-GEIGY CORPORATION (US) | 1997-09-23 | — | — | US | disclosed |
| US-5583247-A | PREMATURE POLYMERIZATION STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0737659-A1 | 7-Substituted quinone methides as inhibitors for unsaturated monomers | CIBA-GEIGY AG (CH) | 1996-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060155140-A1 | Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors | SQOR, NQO1, NQO2 | ATM 2227/4885NPC1 3524/4885KMT2A 2450/4885 |
| US-20040010159-A1 | Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors | SQOR, NQO1, NQO2 | ATM 2160/4885NPC1 3451/4885KMT2A 2522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.